Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

Publisher Website
Google Scholar
Abstract
PURPOSEA phase II trial was conducted to determine the activity of prolonged oral etoposide in platinum-resistant and platinum-sensitive ovarian carcinoma.PATIENTS AND METHODSPlatinum-resistant dis...